trials4us
about this site   |   career opportunities   |   contact us

Ongoing Trials


 

Thank you for your interest in taking part in our ongoing trials.

 

 

At times Richmond Pharmacology may be involved in a number of different clinical trials involving healthy volunteers, patients and other specialised volunteer panels.

 


Do you have a confirmed medical history of asthma?


We are reaching out to volunteers to take part in a clinical trial of a new medicine new medicine being developed to control asthma symptoms. By volunteering you will be helping us to improve current treatments available to other patients like you.

  • Study summary

You may be suitable to take part in this study if you are aged 18 to 77 (inclusive) and you have mild to moderate asthma, but are otherwise healthy. This study will be carried out at our clinical trials unit at Croydon University Hospital in South London. Study participation will involve one initial screening appointment at our unit to check that you are medically suitable to take part, a one night residential stay at our unit and 4 out-patient visits if you are included in the study. 

  • Study dates
Screening appointments will be held through to Friday 12 September inclusive.

Residential visit Cohort 7
Admission: Tuesday, 22nd September
Dismissal: Wednesday, 23rd September

Outpatient visits 
Visit 1: Thursday, 2nd October
Visit 2: Monday, 3rd November
Visit 3: Monday, 17th November

Follow-up visit: Monday, 15th December


Residential visit Cohort 8
Admission: Wednesday, 23rd September
Dismissal: Thursday, 24th September

Outpatient visits 
Visit 1: Friday, 3rd October
Visit 2: Tuesday, 4th November
Visit 3: Tuesday, 18th November

Follow-up visit: Tuesday, 16th December

  • Reimbursement for your time
In recognition of the time involved in taking part in this study, you will receive 450 on completion of the study and a discretionary bonus payment of 220 provided you comply fully with all the study requirements. The total amount you could receive is 670. Travel assistance will be provided for the screening visit and study visits if you are included in the study.

  • Speak to our Volunteer Recruitment team
If you are interested in finding out more Click here to register

Email asthma@richmondpharmacology.com for details

Or call us weekdays between 09h00 and 17h00 on +44 (0) 208 664 5200 (choose option 1) to speak to a member of our Volunteer Recruitment team.


Ref:  ST1_MAY 2014 (web story)

The contents of this email have been approved by an ethics committee. Any response to this advertisement will be recorded.  Your response will not place you under any obligation to participate in this trial.

You may be required to remain resident in the unit until resolution of any safety issues, after which you will be discharged from the unit. 


Register now for more details!


Are you a healthy male or female aged 18 to 45?

Have you ever wondered how new medicines are researched?

Be part of that development process

  • What is this all about?

We are conducting a clinical research study with a medicine which is being developed for the treatment of very rare diseases related to the immune system as the current treatments are limited due to availability and costs.

The results from this study will help us to determine whether the study medication is a safe and effective medicine for these rare immune diseases and to design further clinical trials. It will also help us to decide the most effective dose and the most convenient way to administer the study medication to patients.

The trial is being conducted at Richmond Pharmacology Ltd only.

  • Who is suitable for this study?

To qualify for participation:

  • Be a non-smoking healthy male or female, aged between 18 and 45, inclusive, at screening.

  • If you are a female volunteer, you must be of non-childbearing potential; either surgically sterilised or post-menopausal (you have not had menstrual periods for at least 1 year and confirmed by FSH > 25IU/mL).

  • Have a body mass index (BMI) between ≥18.5 and ≤30.0 kg/m2 (inclusive) at screening. You can use this link to calculate your BMI

  • Be willing to use acceptable contraceptive methods, avoid unprotected sex, and donating eggs or sperm until 3 months after treatment.

Other restrictions and exclusions apply - please ask for details.

  • Study Participation

This study is being conducted at our research facility at Croydon University Hospital in London. If you are interested in taking part you will need to contact us to register your interest.

You will need to attend one screening visit up to 10 weeks before the dose of the study medication.

If suitable, you will be vaccinated against meningitis and pneumonia before you are given the study medication. You will be vaccinated at least eight weeks prior to administration of the study drug hence the long run in period.

If you are medically suitable following your screening visit and vaccinations, you will be required to stay at our Research unit for 1 in-house period of 5 days and 4 nights during which you will receive a single dose of the study medication.
After this you will need to attend 6 outpatient visits. The in-house stay and follow-up periods may be extended if necessary for your safety.

You will be involved in the study for up to 20 weeks.

Study Dates

Screening appointments will be held through to Monday 25th August with the admission for this study due to start 27 October 2014.

Summary Dates

1st vaccination: 21-26 AUGUST, to be confirmed once screening is completed

2nd vaccination: 18-26 SEPTEMBER, 4 weeks after the first vaccination


Admission (one per day): 27 OCTOBER to 10 NOVEMBER

Dismissal: 10 NOVEMBER to 14 NOVEMBER 


Outpatient visits: Day 8, Day 15, Day 29, Day 43, Day 57


Follow-up: Day 71


Please ask a member of our Volunteer Recruitment Team for full details.

  • What do I get if I decide to take part in this study?

Apart from helping medical research, you will also be paid for your time if you are included into the study.

Please note that payments will be made on a pro rata basis through the duration of the study. Please ask a member of the team for more details.

All payments are based purely on the duration of the study and expenses incurred and not on the inconveniences or risks involved. In recognition of the time and effort involved in taking part in this study, you will be paid 1,170 on completion of the study, once follow-up results are confirmed, checked and deemed satisfactory by the Research Doctor. This payment includes all travel expenses.

You may be paid a bonus of 580 subject to your satisfactory compliance with this document (Subject Information/Informed Consent Form), the Richmond Pharmacology Volunteer Charter and all unit rules (unit regulations). However, the bonus payment is issued at the discretion of RPL, meaning RPL is not in any way obliged to pay these monies under the terms of the contract with the volunteers.

The total amount that you could be paid for completion of the full study is 1,750.

If we ask you to come for a rescreening visit or the vaccinations are split over 2 visits, we will pay 40 for each additional visit.

To receive each of these payments you will need to have complied with the study requirements. If we withdraw you from the study, you may receive a pro-rata sum if certain conditions are met. These payment rates only apply to volunteers who have been included into the study i.e. have received a dose on Day 1.


All final study payments due to you will be paid 21 working days after your final follow-up visit


  • Want to find out more?
If you are interested in finding out more Click here to register

Email volunteer@richmondpharmacology.com for details

Or

Call us on +44 (0)20 8664 5200 (choose option 1) and speak to a member of our Volunteer Recruitment Team.

A detailed information sheet is available on request.



Ref: SI1_SEPTEMEBR 2013 (email text)

The contents of this web page have been approved by an ethics committee. Any response to this advertisement will be recorded.  Your response will not place you under any obligation to participate in this trial.


You may be required to remain resident in the unit until resolution of any safety issues, after which you will be discharged from the unit.


AD REF: C13031_web story_version 2.0_29.11.13


Register now for more details!

 

Healthy Volunteer Trials

 

Please choose from the list below the trial you are interested in:

 

 

 

 

Other Trials

 

Please choose from the list below the trial you are interested in:

 



 

Please upgrade
your Flash Player

Watch our short video
See info about ongoing trials at
St George's and Mayday Hospitals

Recommend a friend and you
could earn between £90 - £350
Give blood for up to £60 and
also receive £5 for travel expenses

Please upgrade
your Flash Player
Find Trials4us on Facebook
© 2014 Richmond Pharmacology Ltd. All rights reserved. | Clinical Trials | Medical Volunteer | Drug Trials